Presentation GI2 2012 The BioFreedom™ DES: Late Results, Technology Challenges, and Next Steps Presenter: Eberhard Grube April 13, 2012
Presentation GI2 2012 Rationale and Background to Treat Resistant Hypertension with Renal Denervation Presenter: Martin B. Leon April 13, 2012
Presentation Exenatide Reduces Final Infarct Size in Pts with STEMI and Short Duration of Ischemia Presenter: Jacob L?nborg April 13, 2012
Presentation GI2 2012 How to Reduce Contrast Induced Nephropathy in Interventional Procedures Presenter: Ron Waksman April 13, 2012
Presentation GI2 2012 New Bifurcation (+ left main) Stent Designs and Clinical Results Presenter: Martin B. Leon April 13, 2012
Presentation GI2 2012 10 Reasons Why the Metallic Drug-eluting Stent Should be Replaced by Bioresorbable Scaffold Presenter: Patrick W. Serruys April 12, 2012
Presentation GI2 2012 Starting with the Idea: Defining the Unmet Needs Presenter: Martin B. Leon April 12, 2012
Presentation GI2 2012 How to Improve TAVR Safety? The Role of Ancillary Devices Presenter: Martin B. Leon April 12, 2012
Presentation Clinical Outcomes After TAVR Using Valve Academic Research Consortium Definitions Presenter: Philippe Genereux April 12, 2012